middle.news
Argenica Secures $1.5M to Advance Pivotal Stroke Drug Trial
10:02am on Friday 20th of June, 2025 AEST
•
Biotechnology
Read Story
Argenica Secures $1.5M to Advance Pivotal Stroke Drug Trial
10:02am on Friday 20th of June, 2025 AEST
Key Points
Awarded up to $1.5M from Australian Government’s MRFF TTRA program
Initial $1M tranche secured, $500K contingent on milestones and commercial potential
Funding supports Australian activities in global Phase 2b/3 pivotal trial of ARG-007
Phase 2 trial recently completed with strong recruitment, data expected Q3 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
AGN
OPEN ARTICLE